“MUST READ”
The FDA’s Experience with
Emerging Genomics Technologies—Past, Present, and Future We're trialling a new
version of this page and we'd like your opinion, send feedback.
tags: Pocket
weeklylinks
Will CRISPR mushroom change
the GM debate? As the USDA clears a CRISPR mushroom for sale, FLG Content
Manager Liz Harley asks if gene-editing will clear the air around GMOs. I’m
inclined to agree with him.
DISRUPTION,
REVOLUTION
The Augmented Human Being I
worry about a lot of things. I encourage people to worry about a lot of things,
but worry in the sense of taking action, doing something about it and being
cautious as you do something about it—doing safety engineering. E…
tags: Pocket
weeklylinks
TOOLS/TECHNIQUES
Long-Range PCR: It’s About
Choosing the Right Enzyme The ability for DNA polymerase to copy a long stretch
of DNA is becoming increasingly important. Why? It has to do with the advances
in our sequencing technologies.
tags: Pocket
weeklylinks
How to Fix Your Bad Cloning
Ratios – Bitesize Bio You open the incubator in the morning and to your dismay
there are a hundred glorious colonies… on your vector-only control plate. This
has happened to me more times than I wish to admit.
tags: Pocket
weeklylinks
HEALTH/MEDECINE
Who are 2016’s Top Innovator’s
for Biotech and Medicine in France? The MIT Technology Review has released it’s
next generation of best and brightest in French Tech. This also includes a
surprising number of Biotech entrepreneurs…
COMPANIES
CRISPR Start-ups There are not
many weeks, not to say days when you cannot read something new about CRISPR. I
have to admit I do not know much about it given my total incompetence in health
related matters.
tags: Pocket
weeklylinks
AstraZeneca launches project
to sequence 2 million genomes One of the world’s largest pharmaceutical
companies has launched a massive effort to compile genome sequences and health
records from two million people over the next decade.
tags: Pocket
weeklylinks
tags: Pocket
weeklylinks
- These are just a few of the ‘best practice’ thoughts we have on tech transfer today. A number of institutions get some or all of this right more often than not; others less so. Given the critical importance that academic technology transfer plays in helping launch new biotechs – and by extension new medicines – we all have a vested interest in optimizing the process.
No comments:
Post a Comment